【24h】

A System For Sphingosine-1-Phosphate Delivery Using The Enzyme Sphingosine Kinase

机译:使用鞘氨醇激酶的鞘氨醇-1-磷酸传递系统。

获取原文
获取原文并翻译 | 示例

摘要

Endothelialization of synthetic vascular grafts and implants is critical in enhancing the biocompatibility of these devices. Sphingosine 1-phosphate (S1P) is a potent chemotactic factor that is abundantly stored in platelets. We believe that the delivery of S1P from a biomaterial will enhance the endothelialization of that material. In vivo, S1P is produced from sphingosine by the enzyme sph-ingosine kinase (SphK). While most SphK is cytosolic, vascular endothelial cells can release an active form of SphK that is able to produce extracellular S1P. This extracellular S1P can interact with a family of G-protein coupled receptors on endothelial cells. Human umbilical vein endothelial cells (HUVEC) express the receptors S1P_1, S1P_2 and S1P_3, with S1P_1 expressed in the highest amount. S1P-induced endothelial cell migration requires signaling through the S1P_1 receptor. Therefore, we hypothesize that a thin coating containing SphK on the surface of a vascular graft will enhance endothelial cell migration onto the graft. In the current study, we have cloned an isoform of human SphK. Additionally, we have modeled the kinetics of the production of S1P by SphK and the equilibrium interaction of S1P with the endothelial cell receptor S1P_1 in an in vitro environment.
机译:合成血管移植物和植入物的内皮化对于增强这些装置的生物相容性至关重要。 1-磷酸鞘氨醇(S1P)是一种有效的趋化因子,已大量储存在血小板中。我们认为,从生物材料中递送S1P会增强该材料的内皮化。在体内,S1P是由鞘氨醇酶鞘氨醇激酶(SphK)产生的。尽管大多数SphK是胞质的,但血管内皮细胞可以释放SphK的活性形式,该形式能够产生细胞外S1P。这种细胞外S1P可以与内皮细胞上的G蛋白偶联受体家族相互作用。人脐静脉内皮细胞(HUVEC)表达受体S1P_1,S1P_2和S1P_3,其中S1P_1的表达最高。 S1P诱导的内皮细胞迁移需要通过S1P_1受体进行信号传导。因此,我们假设在血管移植物表面上包含SphK的薄涂层将增强内皮细胞向移植物上的迁移。在当前的研究中,我们已经克隆了人SphK的同工型。此外,我们在体外环境中模拟了SphK产生S1P的动力学以及S1P与内皮细胞受体S1P_1的平衡相互作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号